Paper Details

  1. Home
  2. Paper Details

[Frontline therapy for classical Hodgkin lymphoma patients].

Author: CasasnovasOlivier, RossiCédric

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
English AbstractA summary of a research paper/publication written in English for a wider audience.

Overview

First-line chemotherapy followed by radiotherapy is the standard treatment for classical Hodgkin's lymphoma. The ABVD protocol is widely used, while BEACOPP is preferred in advanced stages. Positron emission tomography (PET) is now crucial for guiding treatment intensity based on early response evaluation. Despite progress, challenges remain, including managing side effects, optimizing radiotherapy, and exploring the role of new agents like brentuximab vedotin and PD-1 inhibitors.
Paper Details　
Original Abstract of the Article :
FRONTLINE THERAPY FOR CLASSICAL HODGKIN LYMPHOMA PATIENTS. Upfront first-line chemotherapy is indicated for all features of classical Hodgkin's lymphoma, followed by involved node radiotherapy in early stages; the ABVD protocol (doxorubicin (Adriamycin), bleomycin, vinblastine, dacarbazine) is the i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/37458551

データ提供：米国国立医学図書館（NLM）

Treating Classical Hodgkin Lymphoma: A Journey Through Therapy

Imagine a fierce sandstorm sweeping across a vast desert. This is analogous to the battle against classical Hodgkin lymphoma, a type of cancer affecting the lymphatic system. This article explores the current frontline therapies used to combat this aggressive disease.

Standard of Care: ABVD Therapy

The ABVD protocol, a combination of chemotherapy drugs, is considered the gold standard for treating classical Hodgkin lymphoma. While effective, this therapy can have significant side effects. Recent advancements, such as the use of positron emission tomography (PET) scans, have enabled doctors to tailor treatment intensity based on a patient's response. This personalized approach helps to optimize the balance between treatment benefits and potential risks.

Navigating the Complexities of Treatment

This research provides an update on the current landscape of classical Hodgkin lymphoma treatment. It highlights the importance of personalized medicine and the ongoing search for better therapies with fewer side effects. This study is like a roadmap across the shifting sands of lymphoma research, guiding us towards more effective and less burdensome treatments.

Dr.Camel's Conclusion

The fight against classical Hodgkin lymphoma is like a battle against a relentless sandstorm. This study highlights the importance of a comprehensive approach that includes standard therapies, individualized treatment strategies, and continuous research to develop new and improved treatments. This research is like a well in the desert, providing a vital source of information and hope for those battling this challenging disease.

Date :
  1. Date Completed 2023-07-19
  2. Date Revised 2023-07-19
Further Info :

Pubmed ID

37458551

DOI: Digital Object Identifier

37458551

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.